These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22374436)

  • 1. [Therapeutic effect of retinoic acid in lupus nephritis].
    Kinoshita K; Funauchi M
    Nihon Rinsho Meneki Gakkai Kaishi; 2012; 35(1):1-7. PubMed ID: 22374436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beneficial effects of treatment with all-trans-retinoic acid plus corticosteroid on autoimmune nephritis in NZB/WF mice.
    Nozaki Y; Yamagata T; Yoo BS; Sugiyama M; Ikoma S; Kinoshita K; Funauchi M; Kanamaru A
    Clin Exp Immunol; 2005 Jan; 139(1):74-83. PubMed ID: 15606616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment with retinoids in patients with lupus nephritis.
    Kinoshita K; Kishimoto K; Shimazu H; Nozaki Y; Sugiyama M; Ikoma S; Funauchi M
    Am J Kidney Dis; 2010 Feb; 55(2):344-7. PubMed ID: 19628316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroids combined with doublet or single-agent immunosuppressive therapy for active proliferative lupus nephritis.
    Liu B; Ou Q; Tang Y; Fu S; Liang P; Yu Y; Xu Z; Chen Y; Xu A
    Clin Rheumatol; 2019 Sep; 38(9):2519-2528. PubMed ID: 31081535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lupus nephritis: the evolving role of novel therapeutics.
    Rovin BH; Parikh SV
    Am J Kidney Dis; 2014 Apr; 63(4):677-90. PubMed ID: 24411715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic pharmacotherapy for lupus nephritis.
    Moroni G; Ponticelli C
    Expert Opin Pharmacother; 2017 Feb; 18(2):175-186. PubMed ID: 28042710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety of isotretinoin in patients with lupus nephritis: a comprehensive review.
    Miziołek B; Bergler-Czop B; Stańkowska A; Brzezińska-Wcisło L
    Cutan Ocul Toxicol; 2017 Mar; 36(1):77-84. PubMed ID: 27160965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lupus nephritis treatment].
    Santos-Araújo C; Pestana M
    Acta Med Port; 2008; 21(3):259-72. PubMed ID: 18674418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis.
    Choi CB; Won S; Bae SC
    Lupus; 2018 May; 27(6):1007-1011. PubMed ID: 29448881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on the treatment of lupus nephritis.
    Hogan J; Appel GB
    Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):224-30. PubMed ID: 23328501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study.
    Vigna-Perez M; Hernández-Castro B; Paredes-Saharopulos O; Portales-Pérez D; Baranda L; Abud-Mendoza C; González-Amaro R
    Arthritis Res Ther; 2006; 8(3):R83. PubMed ID: 16677395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-dsDNA antibodies and resident renal cells - Their putative roles in pathogenesis of renal lesions in lupus nephritis.
    Yung S; Chan TM
    Clin Immunol; 2017 Dec; 185():40-50. PubMed ID: 27612436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G; Danza A; Khamashta M
    Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine and Human Lupus Nephritis: Pathogenic Mechanisms and Theoretical Strategies for Therapy.
    Pedersen HL; Horvei KD; Thiyagarajan D; Seredkina N; Rekvig OP
    Semin Nephrol; 2015 Sep; 35(5):427-38. PubMed ID: 26573545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose rituximab in refractory lupus nephritis.
    Kotagiri P; Martin A; Hughes P; Becker G; Nicholls K
    Intern Med J; 2016 Aug; 46(8):899-901. PubMed ID: 27242250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in Lupus Nephritis Pathogenesis: From Bench to Bedside.
    Obrișcă B; Sorohan B; Tuță L; Ismail G
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric Lupus Nephritis-Review of Literature.
    Thakur N; Rai N; Batra P
    Curr Rheumatol Rev; 2017; 13(1):29-36. PubMed ID: 27041086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lupus nephritis.
    Agrawal N; Chiang LK; Rifkin IR
    Semin Nephrol; 2006 Mar; 26(2):95-104. PubMed ID: 16530602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lupus nephritis.
    Sauter M; Anders HJ
    Minerva Med; 2007 Dec; 98(6):749-58. PubMed ID: 18299686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
    Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.